Metals Creek Resources has contracted additional drilling at its Ogden Gold Project in Timmins, Ontario, a 50/50 joint venture with Discovery Mining. The new program targets the Thomas Ogden Zone, known for high-grade gold mineralization, including a previous drill hole with 115.51 g/t gold over 9.85m and visible gold. Drilling is expected to begin in about two weeks, following up on promising results from recent holes that showed visible gold. This effort aims to further explore gold-bearing structures near the surface and along the fold axis, potentially advancing the project's development.
Metals Creek's Ogden Gold Project drilling contract is the subject, providing context for readers interested in mining developments. For readers following Basic Materials stocks on Pluang, as of Oct 08, 2026 18:02 WIB, 9 of 38 stocks rose while 28 fell. MP Materials traded at USD 45.47 with a 1-day change of -1.81%, Rio Tinto (ADR) was at USD 91.68 down 1.59%, and Aspen Aerogels Inc rose 1.56% to USD 5.87.
MIND, an AI-native data loss prevention (DLP) platform, was named "Data Loss Prevention Platform of the Year" in the 2026 CyberSecurity Breakthrough Awards. The platform uses advanced AI to discover, detect, and prevent sensitive data leaks across va...
The global Mivan construction market is projected to grow from $3.92 billion in 2025 to $7.05 billion by 2031, at a CAGR of 10.28%. Growth is fueled by demand for rapid mass housing, affordable residential projects, and faster construction enabled by...
RBC Capital has increased its price target for Amgen from $400 to $430, reflecting strong confidence in the biopharmaceutical company's future performance. Amgen's stock has outperformed both the S&P 500 and the broader medical sector recently, suppo...
Tilray Brands reported a wider-than-expected loss of $0.32 per share for Q1 fiscal 2027, missing revenue estimates with $257.1 million, though revenue grew 23% year-over-year. The company achieved record first-quarter gross profit with a 30% gross ma...
UnitedHealth Group is expected to report Q3 earnings of $4.12 per share on $111.3 billion revenue, with investors closely watching medical cost trends and Medicare Advantage membership. The company improved its medical care ratio and operating earnin...
